A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)

NCT01033318 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: MK1809
DRUG: Comparator: Losartan
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC